Among the 135 remaining ADRs, 82 (60.7%) did not reach statistical significance as a signal in VigiBase ® .
← all excerpts
Safety profile of belatacept in a real-life setting: disproportionality analysis of the WHO pharmacovigilance database.
1
—
—
Among the 135 remaining ADRs, 82 (60.7%) did not reach statistical significance as a signal in VigiBase ® .